February 9, 2018 / 2:22 AM / 2 months ago

BRIEF-Tianjin Chase Sun Pharmaceutical unit receives certificate of suitability for european pharmacopeia from EDQM

Feb 9 (Reuters) - Tianjin Chase Sun Pharmaceutical Co Ltd

* Says wholly owned pharmaceutical unit received certificate of suitability for european pharmacopeia (CEP) from European Directorate for the Quality of Medecines(EDQM)

* Certificate issued to etomidate manufactured by the unit and the valid period is five years

Source text in Chinese:goo.gl/jgWS2z

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below